Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy

Publisher： Karger

E-ISSN： 1421-9670|26|1|50-58

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.26, Iss.1, 2006-04, pp. : 50-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renoprotection Provided by Losartan in Combination with Pioglitazone Is Superior to Renoprotection Provided by Losartan Alone in Patients with Type 2 Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 4, 2007-06 ,pp. : 203-211

Karger

Access to resources Recommend Favorite

The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 1, 2017-04 ,pp. : 109-122

Karger

Access to resources Recommend Favorite

Effect of Acarbose on Blood Glucose and Proteinuria in Patients with Diabetic Nephropathy

By  

Nephron, Vol. 85, Iss. 2, 2000-05 ,pp. : 190-190

Karger

Access to resources Recommend Favorite

Effect of Long-Term Administration of Prostaglandin I2 in Incipient Diabetic Nephropathy

By  

Nephron, Vol. 92, Iss. 4, 2002-10 ,pp. : 788-796

Karger

Access to resources Recommend Favorite

Effects of Combination Treatment with Losartan and Trandolapril on Office and Ambulatory Blood Pressures in Non-Diabetic Renal Disease: A COOPERATE-ABP Substudy

By  

American Journal of Nephrology, Vol. 24, Iss. 5, 2004-12 ,pp. : 543-548

Karger

Access to resources Recommend Favorite